Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Mar;96(3):111-7.
doi: 10.1258/jrsm.96.3.111.

Xenotransplantation: where are we today?

M D Dooldeniya  1 , A N Warrens
Affiliations
Review

Xenotransplantation: where are we today?

M D Dooldeniya et al. J R Soc Med. 2003 Mar.
No abstract available

PubMed Disclaimer

Figures

<i>Figure 1</i>
Figure 1
Numbers of cadaveric donors and transplants in the UK and Republic of Ireland, 1991-2000 and patients on the waiting list at 31 December. Statistics prepared by UK Transplant from the National Transplant Database maintained on behalf of transplant services in the UK and Republic of Ireland [www.uktransplant.nhs.uk] (Reproduced by permission)
<i>Figure 2</i>
Figure 2
Direct xenorecognition. Xenogeneic APC presents peptide to the recipient CD4+ T cell via the xenogeneic MHC class II molecules. This results in the production of interleukin 2 (IL-2) by the CD4+ T cell. IL-2 acts on the CD8+ T cell which itself recognizes xenogeneic peptide presented via the MHC class I on the xenogeneic APC
<i>Figure 3</i>
Figure 3
Indirect xenorecognition. Shed antigens from the xenogeneic cell are taken up by the responder antigen presenting cell (APC) to be presented to the CD4+ T cell via MHC class II molecule, which results in generation of the effector mechanism
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Valderrabano F, Jones EH, Mallick NP. Report on management of renal failure in Europe, XXIV, 1993. Nephrology Dial Transplant 1995; 10(suppl 5): 1-25 - PubMed
    1. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int 1993;40: S23-7 - PubMed
    1. Aranzabal J, Perdigo L, Mijares J, Villar F. Renal transplantation costs: an economic analysis and comparison with dialysis costs. Transplant Proc 1991;23: 2574. - PubMed
    1. UK Transplant. United Kingdom Preliminary Data. Bristol: UK Transplant, 2002
    1. Duncan BW. Mechanical circulatory support for infants and children with cardiac disease. Ann Thorac Surg 2002;73: 1670-7 - PubMed